Literature DB >> 3179984

Computed tomography of the ileocecal region.

P M Silverman1, F M Kelvin, M E Baker, C Cooper.   

Abstract

The CT scans in 25 patients without ileocecal pathology and 52 patients with ileocecal abnormalities were retrospectively reviewed. The ileocecal region was identified in 18/25 (72%) of patients without pathology. Thirty of 52 patients with ileocecal pathology had inflammatory disease: Crohn's (13), appendicitis (9), abscess (6), and typhlitis (2). CT was complementary to barium studies, demonstrating wall thickening, pericolonic inflammatory change, masses, fascial thickening, and fistulae. Twenty patients had malignancy: primary carcinoma (9), metastases (7), and lymphoma (4). In all patients with carcinoma a mass was identified. Pericolonic stranding represented tumor extension in 5/6 patients. Metastases were identified as extrinsic ileocecal masses in all 7 patients. Liver, mesenteric and omental metastases were present in 8/20 patients. In patients with lymphoma there was wall thickening and two had additional pericecal lymphadenopathy. In 2 patients with hypoalbuminemia, findings included: wall thickening, mesenteric, and subcutaneous edema.

Entities:  

Mesh:

Year:  1988        PMID: 3179984     DOI: 10.1016/0895-6111(88)90040-7

Source DB:  PubMed          Journal:  Comput Med Imaging Graph        ISSN: 0895-6111            Impact factor:   4.790


  3 in total

1.  Yersinia enterocolitica mesenteric adenitis in a thalassaemic adolescent. Conservative management.

Authors:  P Cianciulli; G Trua; G Papa; L Pacifico; K Granfors; C Chiesa
Journal:  Eur J Pediatr       Date:  1992-02       Impact factor: 3.183

2.  Value of granulocyte scintigraphy in inflammatory bowel disease.

Authors:  J J Kolkman; J C Ross; T H Falke; A S Peña
Journal:  Gut       Date:  1994-11       Impact factor: 23.059

3.  Advanced primary non-Hodgkin's lymphoma of the small intestine in childhood: report of four cases.

Authors:  Y Watanabe; T Ito; K Horibe; Y Ishiguro; Y Nimura
Journal:  Surg Today       Date:  1994       Impact factor: 2.549

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.